BIOMAT Database Logo BIOMAT Database Logo

Synthesis and structure-activity relationships of new 7-[3-(fluoromethyl)piperazinyl]- and -(fluorohomopiperazinyl)quinolone antibacterials. 1990

C B Ziegler, and P Bitha, and N A Kuck, and T J Fenton, and P J Petersen, and Y I Lin
American Cyanamid Company, Medical Research Division, Lederle Laboratories, Pearl River, New York 10965.

Some novel 6-fluoro-7-substituted-1,4-dihydro-4-oxoquinoline-3-carboxylic acids have been prepared. At the N-1 position "standard" substitution was employed with the ethyl, cyclopropyl, and p-fluorophenyl groups being used. At C-7 the introduction of some novel piperazines was made. Most notably, 2-(fluoromethyl)piperazine (10) and hexahydro-6-fluoro-1H-1,4-diazepine (16, fluorohomopiperazine) at the quinolone C-7 position produced products with similar in vitro antibacterial activity as the ciprofloxacin reference. The in vivo efficacy of 1-cyclopropyl-6-fluoro-7-[3-(fluoromethyl)piperazinyl]-1,4-dihydro-4- oxoquinoline-3-carboxylic acid (20) was excellent with better oral absorption than ciprofloxacin (2).

UI MeSH Term Description Entries
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011511 Proteus A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the intestines of humans and a wide variety of animals, as well as in manure, soil, and polluted waters. Its species are pathogenic, causing urinary tract infections and are also considered secondary invaders, causing septic lesions at other sites of the body.
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D004754 Enterobacter Gram-negative gas-producing rods found in feces of humans and other animals, sewage, soil, water, and dairy products.
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D004927 Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI. E coli Infections,E. coli Infection,Infections, E coli,Infections, Escherichia coli,E coli Infection,E. coli Infections,Escherichia coli Infection,Infection, E coli,Infection, E. coli,Infection, Escherichia coli
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents

Related Publications

C B Ziegler, and P Bitha, and N A Kuck, and T J Fenton, and P J Petersen, and Y I Lin
Synthesis and structure-activity relationships of 7-[3-(1-aminoalkyl)pyrrolidinyl]- and 7-[3-1-aminocycloalkyl)pyrrolidinyl]-quinolone antibacterials.
July 1994, Chemical & pharmaceutical bulletin,
C B Ziegler, and P Bitha, and N A Kuck, and T J Fenton, and P J Petersen, and Y I Lin
Structure-activity and structure-side-effect relationships for the quinolone antibacterials.
April 1994, The Journal of antimicrobial chemotherapy,
C B Ziegler, and P Bitha, and N A Kuck, and T J Fenton, and P J Petersen, and Y I Lin
Structure-activity relationships in quinolone antibacterials: design, synthesis and biological activities of novel isothiazoloquinolones.
January 1988, Drugs under experimental and clinical research,
C B Ziegler, and P Bitha, and N A Kuck, and T J Fenton, and P J Petersen, and Y I Lin
Synthesis and antibacterial activity of new tetracyclic quinolone antibacterials.
January 1992, Journal of medicinal chemistry,
C B Ziegler, and P Bitha, and N A Kuck, and T J Fenton, and P J Petersen, and Y I Lin
Quinolone antibacterials: synthesis and biological activity of carbon isosteres of the 1-piperazinyl and 3-amino-1-pyrrolidinyl side chains.
July 1993, Journal of medicinal chemistry,
C B Ziegler, and P Bitha, and N A Kuck, and T J Fenton, and P J Petersen, and Y I Lin
Structure-activity relationships of the quinolone antibacterials against mycobacteria: effect of structural changes at N-1 and C-7.
February 1996, Journal of medicinal chemistry,
C B Ziegler, and P Bitha, and N A Kuck, and T J Fenton, and P J Petersen, and Y I Lin
Three-dimensional structure-activity relationships and receptor mapping of N1-substituents of quinolone antibacterials.
January 1991, Journal of medicinal chemistry,
C B Ziegler, and P Bitha, and N A Kuck, and T J Fenton, and P J Petersen, and Y I Lin
1-Substituted 7-[3-[(ethylamino)methyl]-1-pyrrolidinyl]-6,8- difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids. New quantitative structure-activity relationships at N1 for the quinolone antibacterials.
May 1988, Journal of medicinal chemistry,
C B Ziegler, and P Bitha, and N A Kuck, and T J Fenton, and P J Petersen, and Y I Lin
Synthesis and structure-activity relationships of 7-diazabicycloalkylquinolones, including danofloxacin, a new quinolone antibacterial agent for veterinary medicine.
February 1992, Journal of medicinal chemistry,
C B Ziegler, and P Bitha, and N A Kuck, and T J Fenton, and P J Petersen, and Y I Lin
Synthesis and structure-activity relationships of new quinolone-type molecules against Trypanosoma brucei.
March 2012, Journal of medicinal chemistry,
Copied contents to your clipboard!